However, while inhibition of eEF2K may be therapeutically beneficial in blocking cancer cell survival and restoring protein synthesis in AD, further studies are required to define its role in different cancer types and at differing stages in tumorigenesis to fully assess its utility as a therapeutic target in oncology. This evidence concerns the gene EEF2K and cancer.